Log in to save to my catalogue

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia...

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2768239119

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Although targeting oxidative phosphorylation (OXPHOS) is a rational anticancer strategy, clinical benefit with OXPHOS inhibitors has yet to be achieved. Here we advanced IACS-010759, a highly potent and selective small-molecule complex I inhibitor, into two dose-escalation phase I trials in patients with relapsed/refractory acute myeloid leukemia (...

Alternative Titles

Full title

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2768239119

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2768239119

Other Identifiers

ISSN

1078-8956,1546-170X

E-ISSN

1546-170X

DOI

10.1038/s41591-022-02103-8

How to access this item